Chemoinformaics analysis of 3,4-methylenedioxy-10-methoxy-7-oxo[2] benzopyrano[4,3-b]benzopyran
| Molecular Weight | 324.288 | nRot | 1 |
| Heavy Atom Molecular Weight | 312.192 | nRig | 26 |
| Exact Molecular Weight | 324.063 | nRing | 5 |
| Solubility: LogS | -5.906 | nHRing | 3 |
| Solubility: LogP | 3.596 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 42.8735 |
| nHD | 0 | BPOL | 21.5865 |
| QED | 0.685 |
| Synth | 2.669 |
| Natural Product Likeliness | 0.906 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.982 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.841 |
| MDCK | 0.0000361 |
| BBB | 0.036 |
| PPB | 0.938447 |
| VDSS | 0.78 |
| FU | 0.0559829 |
| CYP1A2-inh | 0.939 |
| CYP1A2-sub | 0.685 |
| CYP2c19-inh | 0.951 |
| CYP2c19-sub | 0.12 |
| CYP2c9-inh | 0.782 |
| CYP2c9-sub | 0.924 |
| CYP2d6-inh | 0.684 |
| CYP2d6-sub | 0.924 |
| CYP3a4-inh | 0.924 |
| CYP3a4-sub | 0.145 |
| CL | 9.591 |
| T12 | 0.16 |
| hERG | 0.063 |
| Ames | 0.724 |
| ROA | 0.123 |
| SkinSen | 0.09 |
| Carcinogencity | 0.916 |
| EI | 0.263 |
| Respiratory | 0.152 |
| NR-Aromatase | 0.669 |
| Antiviral | Yes |
| Prediction | 0.829722 |